POTASSIUM PHOSPHATES (Potassium Phosphate, Dibasic; Potassium Phosphate, Monobasic) Patent Expiration, LOE Window & CMS Spending

POTASSIUM PHOSPHATES (Potassium Phosphate, Dibasic; Potassium Phosphate, Monobasic) by Fresenius Kabi: FDA Orange Book core substance LOE 2041-10-12, 0 AB generics, $0 2024 CMS Part D & Medicaid spend, and 3 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorFresenius Kabi
FDA Application & PathwayN212832 (NDA)
Exclusivity / Cliff HorizonLong-Dated Protection (2036+)
Core Active-Ingredient LOE Date2041-10-12
Last Listed Patent or Exclusivity Date2041-10-12
Orange Book Patents (*PED Extensions)4 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$0
2024 Medicare Part D Spend$0
2024 Medicaid Spend$0
Reported Wholesale Price Change (CA SB 17)3 WAC filings (max 19.9% 2-yr change)

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Fresenius / Fresenius Kabi across sibling Meru public-data platforms.